KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Other Non-Current Assets: 2017-2025

Historic Other Non-Current Assets for Elanco Animal Health (ELAN) over the last 7 years, with Sep 2025 value amounting to $306.0 million.

  • Elanco Animal Health's Other Non-Current Assets rose 1.32% to $306.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $306.0 million, marking a year-over-year increase of 1.32%. This contributed to the annual value of $311.0 million for FY2024, which is 8.80% down from last year.
  • As of Q3 2025, Elanco Animal Health's Other Non-Current Assets stood at $306.0 million, which was down 0.65% from $308.0 million recorded in Q2 2025.
  • Elanco Animal Health's 5-year Other Non-Current Assets high stood at $651.0 million for Q1 2024, and its period low was $302.0 million during Q3 2024.
  • In the last 3 years, Elanco Animal Health's Other Non-Current Assets had a median value of $341.0 million in 2023 and averaged $396.0 million.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first spiked by 76.42% in 2024, then plummeted by 52.07% in 2025.
  • Over the past 5 years, Elanco Animal Health's Other Non-Current Assets (Quarterly) stood at $390.0 million in 2021, then fell by 3.08% to $378.0 million in 2022, then fell by 9.79% to $341.0 million in 2023, then decreased by 8.80% to $311.0 million in 2024, then increased by 1.32% to $306.0 million in 2025.
  • Its last three reported values are $306.0 million in Q3 2025, $308.0 million for Q2 2025, and $312.0 million during Q1 2025.